# Anti-Inflammatory Treatment of Schizophrenia

> **NCT01514682** · NA · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 50 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Anti-inflammatory Combination Therapy
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01514682
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2017-04-17
- **Final completion:** 2017-04-17
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01514682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01514682, "Anti-Inflammatory Treatment of Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01514682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*